Philadelphia Neurologic Institute Foundation Inc
Nonprofit profile at a glance
- EIN
- 810910550
- IRS 990 coverage
- 2019–2024
- Forms available
- Form 990 2024, Form 990-EZ 2018
- Location
- Pennington, NJ, USA
- Phone
- 2159629600
- Rating
- 62
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Fund Raising and/or Fund Distribution
Reported finances
- Revenue
- $110,863
- Expenses
- $74,723
- Assets
- $46,520
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
7 people listed
Executive titles in this filing
- EROL VEZNEDAROGLU MD (PRESIDENT)
People named in this filing
- EROL VEZNEDAROGLU MD (PRESIDENT)
- DONALD J DAMICO (TREASURER)
- THOMAS KURTZ (SECRETARY)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Philadelphia neurologic institute foundation, inc. (formerly gni neurosciences foundation, inc.) (the "corporation") shall be organized and operated exclusively to carry out those tax-exempt purposes enumerated under section 501(c)(3) of the internal revenue code of 1986, as amended, or the corresponding provisions of any subsequent tax law of the united states, including, but not limited to, raising funds for the purpose of: (i) educating the public to improve recognition of the signs and symptoms of neurological injuries/diseases, such as stroke; (ii) educating clinicians (physicians, rns, ems squads, etc.) to better recognize and appropriately treat neurological injuries/diseases; (iii) educating local communities of the capabilities and availability of neurosurgical and neurological specialists in their areas; (iv) conducting training and funding research intended to raise awareness of and further develop neurosciences treatments and devices; (v) providing incubator facility for ne
What it reported doing in 2024
Philadelphia neurologic institute foundation, inc. (formerly gni neurosciences foundation, inc.) (the "corporation") shall be organized and operated exclusively to carry out those tax-exempt purposes enumerated under section 501(c)(3) of the internal revenue code of 1986, as amended, or the corresponding provisions of any subsequent tax law of the united states, including, but not limited to, raising funds for the purpose of: (i) educating the public to improve recognition of the signs and symptoms of neurological injuries/diseases, such as stroke; (ii) educating clinicians (physicians, rns, ems squads, etc.) to better recognize and appropriately treat neurological injuries/diseases; (iii) educating local communities of the capabilities and availability of neurosurgical and neurological specialists in their areas; (iv) conducting training and funding research intended to raise awareness of and further develop neurosciences treatments and devices; (v) providing incubator facility for neurosciences and mental health related start-ups; (vi) organizing and providing facilities for large conference meetings; (vii) providing laboratory and clinical training facilities for development of next generation neurosciences innovations; (viii) providing resources for associated/visiting faculty, associations and organizations; (ix) supporting a dedicated, comprehensive neurosciences institute designed to attract nationally recognized clinicians and house dedicated, state-of- the-art research, inpatient and outpatient clinical and rehabilitation facilities so as to treat patients with the most advanced clinical techniques in both neurosciences and mental health focused on improved patient outcomes; (x) supporting on-site, dedicated office space for all neurosciences industry stakeholders who are focused on medical advancement and cure; (xi) supporting the development of mental health-related advancements; (xii) supporting dedicated academic research in the area of neurosciences and related disciplines including biomedical engineering, (xiv) supporting research, development and commercialization of promising neurosciences and rehabilitation innovations; and (xv) supporting the education of clinicians focused on advancing and improving patient care in the field of neurosciences.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Hybrid. The nonprofit split its reported program spending across 63% for direct work, and 37% for grants.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of voting board members are independent and some filing-based governance responses are negative or unanswered.
Rating breakdown
- Financial Efficiency: 71
- Transparency & Controls: 94
- Accountability: 12
- Sustainability: 66
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 67.4%; rating input score 67
- Program expense ratio: 100%; rating input score 100
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Limited
- Grant itemization coverage: 100%; rating input score 100; 80th percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 0%; rating input score 0; 7th percentile among comparable filings
- Governance controls: 2 of 7 controls in place; rating input score 29
- Conflict-of-interest policy: Pass
- Whistleblower policy: Fail
- Document-retention policy: Fail
- CEO compensation review process: NotApplicable
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Fail
- Board meeting minutes documented: Pass
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: 32.6%; rating input score 84; 84th percentile among comparable filings
- Total-asset coverage ratio: 0.62; rating input score 29; 29th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 80; 80th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 69; 69th percentile among comparable filings
Growth
- Program expense growth: -17.4% per year; rating input score 0; 7th percentile among comparable filings
- Revenue growth: -8.1% per year; rating input score 0; 7th percentile among comparable filings
- Asset growth: -10.9% per year; rating input score 0; 6th percentile among comparable filings
Details
- Where the money goes: 67.4% of revenue deployed · 100% of spending went to programs
- Governance: 0 of 7 board members independent · 2 of 7 filing controls reported
- Programs: 2 filed program accomplishments · $75K in reported program spending
- Leadership: top reported pay $0 · 7 people listed
- Consistency: 15 of 15 current checks pass
- Schedules: 6 filed schedules · includes major donors and grants
- Filing history: 5 filing years from 2019 to 2024
- Contacts: How to reach this organization
- Money network: 2 filed money-flow records
- Related organizations: 1 filed related-organization link
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Accountability: Independent voting board scored 0/100.
- High — Accountability: Governance controls: 4 of 6 not reported.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 29/100.
- High — Growth: Asset growth scored 0/100.